The Vanguard Group 13D and 13G filings for Infinity Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:22 am Sale | 2022-12-30 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | The Vanguard Group | 5,313,679 5.950% | -469,754 (-8.12%) | Filing |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ | The Vanguard Group | 5,783,433 6.500% | 3,888,514 (+205.21%) | Filing |